The World Health Organization is drawing up a list of reasons why the U.S. should remain in the WHO for its own good, two ...

Novo Nordisk, the largest European company by market capitalization, has achieved worse than expected results for its new slimming drug CagriSema ...

Researchers at LSU’s Pennington Biomedical Research Center are working with the Lancet Commission on Clinical Obesity, in ...

The Centers for Medicare and Medicaid Services (CMS) identified 15 drugs it has selected for price negotiations with drug ...

A panel of health experts looking at obesity announced that the definition of the condition should be split into two ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

An international panel of researchers say the measure is too simplistic and focuses too much on weight versus wellness.

Medicare adds 15 drugs, including Ozempic and Wegovy, to its price negotiation list, aiming to save billions. Incoming Trump ...

Diabetes and weight loss drugs Ozempic and Wegovy have been added to the list of medications selected for Medicare price ...

Instead of using the controversial body mass index, or BMI, to assess weight, an international group of scientists proposes ...

Understanding the definition of obesity: experts examine the limitations of body-mass index (BMI) and propose alternative measures for adiposity.

A global group of experts has suggested a new approach to diagnosing and treating obesity that does not rely solely on the much-contested body mass index (BMI).